Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT02613234
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with epilepsy at least 1 year according to the 2010 International League Against Epilepsy (ILAE) criteria.
* Aged 18 to 65 years old.
* The seizure is not well-controlled by antiepileptic drugs, the patient cannot tolerant the side effect of antiepileptic drugs, or the patient is not satisfied with the curative effect.
* The dose of antiepileptic drugs must be stable in the last 4 weeks.
* The patient or his/her family member is able to recording the frequency of seizures and complete the trial.
Exclusion Criteria:
* History of status epilepticus in the last 12 weeks according to the definition by Neurocritical Care Society (NCS) 2012.
* History of transcranial direct current stimulation, repetitive transcranial magnetic stimulation, vagus nerve stimulation, trigeminal nerve stimulation or deep brain stimulation. History of pacemaker or other metal equipment implantation.
* History of skull defect, brain tumor, encephalitis, progressive encephalopathy and other progressive diseases of central nervous system.
* History of severe cardiac, hepatic, renal, hematologic diseases, or other progressive and systemic diseases, or during pregnancy.
* History of major depression and other mental disturbance, color blindness, hearing or language disorder who is not able to complete the trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02613234
Study Brief:
Protocol Section:
NCT02613234